Page last updated: 2024-08-21

cepharanthine and Bone Cancer

cepharanthine has been researched along with Bone Cancer in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KIMURA, C; KONDO, M; NAGANO, S; ONIZUKA, T1
Akaki, S; Asaumi, J; Himei, K; Hiraki, Y; Kanazawa, S; Katsui, K; Komatsu, M; Kuroda, M; Takemoto, M; Wang, Y1
Arai, Y; Kakehi, Y; Kanba, T; Shichiri, Y; Yoshida, O; Yoshida, S1
Arai, Y; Hiura, M; Kakehi, Y; Kanematsu, A; Segawa, T; Shichiri, Y; Yoshida, O1
Hashimura, T; Kakehi, Y; Kanematsu, A; Segawa, T; Yoshida, O1

Trials

1 trial(s) available for cepharanthine and Bone Cancer

ArticleYear
[Intraarterial chemotherapy for metastatic renal cell carcinomas: combination with MDR-overcoming agents].
    Hinyokika kiyo. Acta urologica Japonica, 1994, Volume: 40, Issue:10

    Topics: Alkaloids; Antineoplastic Combined Chemotherapy Protocols; Benzylisoquinolines; Bone Neoplasms; Carcinoma, Renal Cell; Doxorubicin; Drug Resistance, Multiple; Humans; Infusions, Intra-Arterial; Kidney Neoplasms; Vinblastine

1994

Other Studies

4 other study(ies) available for cepharanthine and Bone Cancer

ArticleYear
[EFFECT OF CEPHARANTHIN FOR LEUCOPENIA IN MALIGNANT BONE TUMOR].
    Kumamoto Igakkai zasshi. The Journal of the Kumamoto Medical Society, 1965, Jan-25, Volume: 39

    Topics: Alkaloids; Benzylisoquinolines; Bone Neoplasms; Humans; Leukopenia; Pharmacology

1965
Cepharanthin enhances adriamycin sensitivity by synergistically accelerating apoptosis for adriamycin-resistant osteosarcoma cell lines, SaOS2-AR and SaOS2 F-AR.
    International journal of oncology, 2004, Volume: 25, Issue:1

    Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Apoptosis; Benzylisoquinolines; Biological Transport; Bone Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Osteosarcoma

2004
Intra-arterial infusion chemotherapy in combination with a biscoclaurine alkaloid, Cepharanthin, to treat bone metastasis arising from renal cell carcinoma.
    International journal of urology : official journal of the Japanese Urological Association, 1994, Volume: 1, Issue:4

    Topics: Alkaloids; Angiography; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Benzylisoquinolines; Biopsy; Bone Neoplasms; Carcinoma, Renal Cell; Epirubicin; Humans; Ilium; Injections, Intra-Arterial; Kidney Neoplasms; Male; Middle Aged; Recurrence; Tomography, X-Ray Computed; Vinblastine

1994
[Circumvention of the multidrug-resistance in renal cancer by bisbenzylisoquinoline].
    Hinyokika kiyo. Acta urologica Japonica, 1993, Volume: 39, Issue:12

    Topics: Alkaloids; Antineoplastic Combined Chemotherapy Protocols; Benzylisoquinolines; Bone Neoplasms; Carcinoma, Renal Cell; Cisplatin; Doxorubicin; Drug Resistance; Humans; Infusions, Intra-Arterial; Kidney Neoplasms; Tumor Cells, Cultured; Vinblastine

1993